F amily history of premature coronary artery disease or myocardial infarction is often sought during the initial clinical encounter, but a definitive genetic diagnosis is rarely made. We review potential monogenic causes of coronary artery disease and explore the clinical genetics that might initiate molecular testing or specialist referral.
Coronary artery disease (CAD) and myocardial infarction (MI) are often viewed as prototypical complex genetic disorders. However, when the presentation occurs early in life or when the disease appears to segregate in families, it may be related to one of several Mendelian disorders with CAD or MI as part of the phenotypic expression. The most useful evaluation tool at present is a definitive, carefully curated family history focused on the identification of the limited number of testable genetic causes while avoiding additional testing for conditions with low pretest probability. Here we review the potential genetic causes to consider when assessing a patient with premature MI or CAD and outline recommendations for genetic testing or consideration of referral to a center specializing in cardiovascular genetics. A 35- year-old man presents with crescendo angina culminating in rest pain with ECG changes in the precordial leads and associated biomarker abnormalities. He has no past medical history and has no risk factors for vascular or metabolic disease. His most recent fasting lipid panel was completely normal. An initial family history is notable for "heart" problems in his mother's side of the family. At coronary angiography he is found to have a 95% stenosis of his proximal left anterior descending artery which is successfully treated by percutaneous coronary intervention including a drug-eluting stent. A subsequent detailed family history with objective confirmation reveals that his mother presented with an acute left anterior descending syndrome at the age of 42 and two of her male siblings underwent coronary revascularization before the age of 40. The patient's maternal grandfather died suddenly of unknown causes at the age of 44, and a distant male cousin also had a "blocked artery" at the age of 33 (see pedigree in Figure 1 ). An extensive investigation for known causes of premature CAD is unremarkable.
Typical Case

Heritability of MI
For over half a century MI has been recognized to cluster in families 1 leading to a long-held notion that heritable factors play a role in its development. 2 This clustering, however, may occur in different patterns reflecting underlying differences in the likely genetic influence particular to each family. Many individuals present with MI or CAD later in life and have multiple traditional risk factors in addition to a family history that may reveal other affected relatives. A pedigree reflecting this frequent type of familial clustering is seen in Figure 2 . As shown, multiple known risk factors seem to be associated with the observed MI/CAD, which itself develops later in life with a range of clinical presentations. While there may be genetic factors underlying the development of MI/CAD in this family (many individuals in the population sharing these risk factors will not develop MI or CAD), the presentation here is likely multifactorial (ie, the culmination of genetic and nongenetic factors), reflecting the presence of shared genetic and environmental factors among family members. In addition, the clustering in such families does not typically fit a Mendelian pattern, but rather suggests a complex inheritance (ie, the phenotype may be under the influence of multiple causal genes), a substantial dependence on an environmental factor or factors (eg, tobacco), or even misdiagnosis of some of the pedigree members.
A discrete pattern of familial clustering is observed in the pedigree described in the introduction (Figure 1) , with several notable features. Multiple family members are affected at a precocious age without the influence of traditional environmental risk factors, increasing the likelihood that a genetic factor of strong effect is influencing the inheritance of the trait. The specific pattern-both genders are affected from multiple generations and male-to-male transmission is observed-suggests autosomal dominant inheritance. We also see several common confounders typical of pedigrees with a strong history of MI/CAD. Phenocopies (the presence of the trait in an individual who has not inherited the causal allele) can be common given the high population prevalence of MI/ CAD and the restricted biological resolution of the techniques used to diagnose MI/CAD. This is likely the case for the proband's maternal grandmother (individual I-2) who suffered an MI later in life, probably unrelated to the inherited cause in the remainder of the family. Incomplete penetrance (an individual who has inherited the causal allele but does not manifest the trait) is also common because of the long subclinical course of atherosclerosis. For example, individual II-7 seems to be a nonpenetrant obligate carrier of the presumed inherited predisposition to MI/CAD given his affected son (individual III-4) but may have subclinical coronary atherosclerotic disease without manifest CAD symptoms. Incomplete history may also give the impression of incomplete penetrance (the proband's maternal grandfather, individual I-1, is probably affected; however, a complete history is not accessible).
The overall degree to which heritable factors influence MI in the population has been estimated using epidemiological 
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August 2014 studies. The most conceptually straightforward of these types of studies is a twin study in which the concordance of disease is compared between monozygotic twins (siblings sharing 100% of their genetic material) and dizygotic twins (siblings sharing 50% of their genetic material on average). 3 Because of a substantial environmental influence on the MI phenotype, dizygotic twins are used as a reference rather than nontwin full siblings to minimize the impact of environment on the phenotypic variance. Through various studies the heritability of MI has been estimated to be ≈50%, [4] [5] [6] meaning that additive genetic variance explains roughly half of the phenotypic variability in the population. However, this may be an underestimate however, because of intrinsic study biases and incomplete ascertainment of cases. An early age at presentation is associated with higher heritability (≤63%), 4 while certain patterns of disease are associated with lower heritability (distal coronary disease, in particular). 5 While informative from a population perspective, these heritability estimates say little about specific biology of individual cases or about the range of potential genes and genetic effect sizes that might act to generate the heritability observed in the disease. 7 To gain insight into an individual's risk (eg, family members of individuals with premature MI), we can turn to lessons learned through studying Mendelian disorders with MI or CAD as major or minor manifestations of the disease.
Inherited Forms of Premature Atherosclerosis
Of the monogenic disorders with definitive evidence of MI or CAD as part of the phenotypic expression (see Table 1 ), many primarily affect plasma lipid levels reflecting the strong etiologic role of lipoprotein biology in the pathogenesis of MI and CAD. The most notable of these involve mutations in the gene encoding the low-density lipoprotein receptor (LDLR), first identified by Brown and Goldstein 8 as they sought to discover the mechanism of familial hypercholesterolemia (FH). FH, a 
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A Clinical Approach to Inherited Premature CAD 561 disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C), tendon xanthomas, corneal arcus at a young age, and premature CAD, is caused by mutations in LDLR leading to defective cellular uptake of low-density lipoprotein cholesterol. When homozygous FH is present (an individual who inherits 2 defective copies of the LDLR gene), CAD can even develop in early childhood or adolescence. As opposed to LDLR mutations, which typically exhibit incomplete dominance or codominance (the phenotype of the heterozygote individual is often intermediate between the 2 homozygote phenotypes), there are additional forms of hypercholesterolemia that exhibit true autosomal dominant or autosomal recessive patterns. Two defective copies of LDLRAP1 are needed to acquire autosomal recessive hypercholesterolemia, a disorder with similar characteristics to individuals carrying LDLR mutations. 9 In contrast, only one gain-of-function mutation is needed in PCSK9 to cause FH3 10 (named as such because it was the third gene discovered to cause FH after LDLR and APOB). 11 Sitosterolemia, a rare autosomal recessive disorder of plant sterol metabolism, presents with clinical features similar to FH including premature CAD and has been linked to mutations in both ABCG5 and ABCG8. There have been mixed results in definitively associating MI or CAD with Mendelian dyslipidemias primarily affecting lipoproteins that are not processed via the LDLR. 12, 13 There have been several attempts to find a molecular basis for apparent Mendelian forms of pure CAD or MI. As one might imagine, such studies are difficult and likely to be confounded by both false-negative diagnoses (eg, family members with significant subclinical CAD labeled as unaffected) and phenocopies (eg, family members with MI because of other causes-such as heavy cigarette smokers-labeled as affected). The first of these studies identified MEF2A as the putative gene responsible for CAD or MI in a large family of 21 individuals (13 of whom were affected with CAD or MI). 14 Linkage analysis assuming an autosomal dominant mode of transmission suggested that the causal gene was located in a region containing 93 genes at chromosome 15q26. Further analysis identified a 21-base pair in-frame deletion in MEF2A that appeared to segregate with disease in this family. When additional sequencing was performed in an independent cohort, however, the same 21-bp deletion (in addition to other mutations) in MEF2A failed to segregate with disease, 15 suggesting that this gene does not play a causal role in CAD/MI. 16 Linkage analysis was successful in another family with apparent autosomal dominant inheritance of premature CAD/MI and metabolic syndrome. The investigators subsequently identified LRP6 (LDLR-related protein 6) as the putative causal gene. 17 This gene seems to be a rare cause of CAD and metabolic syndrome.
Inherited Vasculopathies
There are several inherited disorders without a primary defect in lipid metabolism but with CAD/MI as part of the clinical presentation. Williams-Beuren syndrome (also called Williams syndrome) is a rare disorder caused by a hemizygous deletion in a region of chromosome 7q11. 23 . Initially characterized as the combination of supravalvular aortic stenosis, mental retardation, and characteristic facies, 18 the phenotypic manifestations can involve multiple organ systems. 19 The vascular complications of Williams-Beuren syndrome typically present as stenoses in large-or medium-sized arteries 19 ; however, there have been reports of coronary involvement leading to premature CAD/MI. 20 Fibromuscular dysplasia is another vascular disorder that can affect the coronary arteries as well as other midsized arteries. More common in women than in men, the disorder is often readily recognized on arteriography and can occasionally segregate as an autosomal dominant trait. 21 Mutations in ACTA2, known to cause familial thoracic aortic aneurysms and dissections, have also been associated with a variety of vascular disorders including premature CAD, stroke, and Moyamoya disease. 22 Families with ACTA2 mutations display incomplete penetrance (only half of ACTA2 mutation carriers will develop aortic disease, and other vascular complications are also incompletely penetrant) and striking phenotypic heterogeneity (one family member may exhibit aortic dissection, while another develops CAD, and a third develops stroke). CAD was previously reported to be associated with other vascular dysplastic syndromes including disorders on the aortic coarctation spectrum. However, more recent data do not clearly support such an association. 23 Heterogeneity of the underlying disorders is a significant confounder for such studies, and ultimately a molecular taxonomy of vasculopathies will help to resolve these discrepancies.
In classic homocystinuria, homozygous or compound heterozygous (an individual inheriting 2 independent lossof-function mutations in the same gene) mutations in cystathionine β-synthase lead to defects in sulfur metabolism. These mutations, inherited in an autosomal recessive fashion, lead to mental retardation, ectopic lentis (and other Marfanoid characteristics), as well as thrombosis, including MI. 24 In addition to cystathionine β-synthase, homocystinuria is also caused by recessive inheritance of mutations in the MTHFR gene.
Pseudoxanthoma elasticum is a multisystem disorder characterized by connective tissue calcification, affecting elastic tissue in the arterial media, dermis, and Bruch's membrane in the eye. 25 Patients often present with pseudoxanthomas, the classic cutaneous finding of multiple small yellow-orange papules in the axilla, neck, flank, or abdomen, often described as looking like chicken skin. Arterial complications can precede epidermal changes, however, and include accelerated atherosclerosis because of calcific deposition in the internal elastic lamina. Any arterial bed, including the coronary circulation, can be involved. Pseudoxanthoma elasticum is caused by mutations in the ABCC6 gene and has been described with both recessive and dominant patterns of inheritance. 26
Inherited Aneurysmal Disorders
Kawasaki disease (KD), a childhood febrile mucocutaneous syndrome, 27 can involve the coronary arteries, characteristically leading to coronary aneurysms. Although the majority of these will spontaneously resolve, some will persist as aneurysms, while others will progress to develop coronary stenosis with or without MI. 28 A genetic contribution to KD is just beginning to be uncovered with the reports of several common DNA variants associated with modestly increased risk of KD. [29] [30] [31] There are rare reports of familial forms of KD although the genetic basis of these has been difficult to decipher in the context of a possible unidentified infectious agent. In addition, many KD cases are 562 Circ Cardiovasc Genet August 2014 sporadic, rendering traditional genetic linkage analysis difficult or impossible. Coronary dissection syndromes may also present as premature MI and even in the era of immediate coronary angiography can be missed. The evaluation of premature CAD patients, in particular young women, should include the formal consideration of underlying arterial dissection and a clinical assessment for other manifestations of the relevant vasculopathies including assessment of the thoracic aorta.
Inherited Coagulopathies
Several hypercoagulable states are heritable, and the specter of arterial thrombosis is often raised to explain unusual presentations of MI. However, most of these conditions are not associated with CAD or MI. The most common heritable hypercoagulable syndromes involve mutations in the genes encoding factor V (the most prevalent form of heritable thrombophilia is the factor V Leiden mutation, carried by 3% to 5% of the population), 32 antithrombin, prothrombin (including G20210A, carried by 2% to 3% of the population), 33 and proteins C and S. While carriers of these mutations have varied risk of venous thromboembolism, 34 these are not clearly linked to arterial thrombosis or MI. 33 Antiphospholipid syndrome, in contrast, is associated with both venous and arterial thrombosis and can present with acute MI because of in situ coronary thrombosis. In addition, there is evidence that antiphospholipid syndrome itself can accelerate the development of coronary atherosclerosis. 35 There is a familial form of antiphospholipid syndrome (Online Mendelian Inheritance in Man 36 107320) although the genetic basis of this form is unknown. Inherited dysfibrinogenemia along with other congenital bleeding disorders are reported to be rare causes of arterial thrombosis and MI. 37
Complex Inheritance of CAD and MI
Starting with the identification of an association between a common variant on chromosome 9p21 and MI/CAD, 38, 39 genome-wide association studies have successfully identified over 45 loci associated with the risk of MI/CAD. [38] [39] [40] [41] [42] [43] [44] [45] In both case-control and prospective population-based cohort studies, increasing numbers of risk alleles are associated with increasing odds of developing disease, 42, 44, 46 consistent with a polygenic model where disease is a consequence of inheritance at many loci, each contributing a modest effect on phenotype. It is possible that families with an unusually strong clustering of MI/CAD have a large proportion of these common risk alleles, but this has not been formally studied. Other complex disorders also influence the risk of CAD and MI. There have been ≥157 genetic loci associated with lipid traits, 47 and several of these are associated with increased risk of CAD or MI. 48
Approach to the Patient With Premature MI/CAD
As with any medical evaluation, the approach to the patient with premature MI or CAD begins with a careful history and physical examination ( Table 2) . Unlike most evaluations, however, in which questions regarding family history are often grouped The need for additional objective testing (ie, laboratory testing or clinical imaging directed toward a definitive diagnosis) is largely predicated on the findings from careful assessment of the family pedigree and physical examination ( Table 2 ). In the same vein as objective clinical testing, the role of genetic testing is largely driven by the specific case presentation. The yield of genetic testing is heavily influenced by pretest probability. Given this, routine assessment of large genetic panels is unlikely to be helpful (eg, ordering LDLR sequencing for all patients regardless of clinical suspicion of FH is unlikely to yield meaningful answers in the majority of cases). Finally, until further studies are performed demonstrating a clinical benefit to incorporating markers identified through genome-wide association studies, current guidelines do not support the assessment of these common genetic variants. 49 Referral to a specialized center focusing on cardiovascular genetics should be considered for assistance with diagnosis, interpretation of genetic testing results, risk assessment of unaffected individuals, and consideration of research-based genetic studies. Although hypercholesterolemia is strongly associated with premature MI, nearly half of the premature MI cases may have normal plasma cholesterol levels, 50 reflecting the likely potential of genetic causes other than FH. Families with a clustering of disease, particularly kindreds in which MI/ CAD presents at an early age, in multiple individuals, and with minimal traditional risk factors, should be strongly considered for referral to specific centers routinely performing research-or clinically based exome or genome sequencing. While genomic sequencing may not result in immediate clinical impact for families with apparent Mendelian inheritance of MI/CAD, studies in kindreds such as that depicted in Figure 1 are sources for potential discovery which may impact our understanding of the genetic basis and future management of these disorders.
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